This study evaluated the impact of insomnia and chronic use of benzodiazepines on the cognitive and psychomotor performance of older adults. Three conditions, matched on age, gender, and education, were compared: 20 prolonged users of benzodiazepines for insomnia, 20 unmedicated insomniacs, and 20 good sleepers. The participants completed neuropsychological tests of memory, attention/concentration, psychomotor speed, and executive functions, as well as subjective evaluations of their actual performance. Individuals with insomnia, both medicated and unmedicated, performed worse than good sleepers on the attention/concentration factor. There was no other objective evidence of performance impairments. However, unmedicated insomniacs had lower performance expectancies and subjectively rated their performance more negatively relative to medicated insomniacs and good sleepers. Both insomnia conditions also rated their performance as lower compared with their perceived potential. It is suggested that the attention/concentration difficulties experienced by medicated and unmedicated older adults with insomnia may be linked to a state of hyperarousal. The discrepancies between subjective reports of daytime deficits and objective impairments may reflect a generalized faulty appraisal of sleep and daytime functioning among individuals with insomnia complaints. The implications of those findings for the assessment and treatment of late-life insomnia are discussed.
I
NSOMNIA is a widespread health complaint in older adults. Survey data have indicated that nearly 25% of people aged 65 to 79 years experience chronic sleep difficulties (Ford & Kamerow, 1989; Mellinger, Baiter, & Uhlenhuth, 1985) . Individuals with insomnia often report daytime impairments that they attribute to their sleep difficulties (Broman, Lundh, Aleman, & Hetta, 1992; Morin, 1993) . Among these problems are fatigue, cognitive impairment (e.g., concentration and memory), behavioral inefficiency (e.g., coping with irritations and accomplishing tasks), and disturbed quality of social interactions (Gallup Organization, 1991; Zammit, 1988) . Furthermore, the fear of poor daytime performance after a poor night's sleep is often the main concern of people with insomnia (Hauri, 1997) . Normal age-related changes in sleep patterns occurring in late life, combined with the increased prevalence of health problems and medication use, place older adults at greater risk for sleep complaints and their associated daytime consequences (Morin, Blais, & Mimeault, 1998; Regenstein, 1992) .
The higher incidence of sleep disturbances in elderly individuals is paralleled by increased use of sedative hypnotics (Ohayon, Caulet, & Lemoine, 1996) , with the benzodiazepines being the most frequently prescribed drugs for insomnia (Walsh & Engelhardt, 1992) . Prolonged usage of hypnotic medications is usually not recommended because of their adverse effects on cognitive and psychomotor functioning, as well as their associated risks of tolerance and dependence (Ashton, 1994; National Institutes of Health, 1991) . These risks are more pronounced in elderly people because of a slower metabolism of benzodiazepines with aging, which, in turn, leads to both a reduction in their elimination and an increase in sensitivity to their secondary effects (i.e., sedation; Monane, 1992) . Long-acting agents also have residual effects that can impair cognitive functions (Greenblatt, 1992) and increase the risk of falls and hip fractures (Ray, Griffin, & Downey, 1989; Sorock & Shimkin, 1988) , as well as the risk of car accidents (Ray, Fought, & Decker, 1992) . Despite these risks, the large majority of longterm (>1 year) users of hypnotics are older adults, with one study reporting that 38% are aged between 50 and 64 years old and 33% are older than 65 (Mellinger et al., 1985) .
The effects of chronic use of benzodiazepines on objective performance tests have not yet been investigated in older adults with insomnia. However, some studies conducted with anxiety disorders patients have shown that chronic users of benzodiazepines performed poorly on tasks involving visuospatial abilities, sustained attention, psychomotor functions, memory, and verbal learning skills (Golombok, Moodley, & Lader, 1988; Tata, Rollings, Collins, Pickering, & Jacobson, 1994) . Conversely, other studies found no serious deficits among regular and long-term users of benzodiazepines Lucki, Rickels, & Geller, 1985 . These authors have suggested that tolerance to the adverse effects of benzodiazepines on psychomotor and cognitive functions develops following prolonged usage.
Neuropsychological evaluation of unmedicated insomniacs has also yielded conflicting results. Negative findings have been reported with younger insomniacs (e.g., Adam, Tomeny, & Oswald, 1986; Broman et al., 1992; Mendelson, Garnett & Linnoila, 1984; Schneider-Helmert, 1987; Seidel et al., 1984) . Of the two studies conducted with older adults, one showed that performance was only minimally affected by poor sleep (i.e., Stone, Morin, Hart, Remsberg, & Mercer, 1994) , whereas the other found that only a verbal memory task was related to objective sleep disturbances measured by polysomnography (Hart, Morin, & Best, 1995) .
Despite consistent complaints of poor daytime functioning among individuals with insomnia, the lack of conclusive data on objective impairments has led researchers to investigate the role of subjective evaluation of performance. Relative to good sleepers, individuals with insomnia evaluate their performance on neuropsychological tests more poorly, even if they perform relatively well (Broman et al., 1992) . Increasing evidence has also suggested that the subjective appraisal/perception of sleep and nonspecific cognitive and psychological factors are important determinants of older adults' complaints about insomnia and daytime functioning. For example, older adults with insomnia tend to endorse stronger dysfunctional beliefs and attitudes about sleep loss and its impact on daily functioning relative to self-defined good sleepers (Morin, Stone, Trinkle, Mercer, & Remsberg, 1993) . In addition, performance impairments on neuropsychological testing are more strongly associated with subjective (as measured by daily sleep diaries) than with objective (as measured by laboratory polysomnography) sleep disturbances (Hart et al., 1995) . It is then plausible that an individual's expectancies and self-evaluation might also influence his or her appraisal of and actual neuropsychological performance.
In summary, given the more prevalent sleep difficulties and the increased usage of benzodiazepines in late life, it is plausible to expect greater impairments of daytime functioning among medicated or drug-free older adults compared with those reported in younger insomniacs. Although older adults are the most frequent users of benzodiazepines, no study has yet investigated the possible adverse effects of the long-term use of this medication in elderly individuals. Finally, as subjective evaluation and related psychological factors seem to be important determinants of performance, it is important to investigate whether those factors also influence the daytime performance of older adults with chronic insomnia. Accordingly, the present study evaluated the impact of sleep disturbances and chronic use of benzodiazepines on the cognitive and psychomotor performance of older adults. The objectives of the study were to compare the neuropsychological performance of medicated and unmedicated older adults with insomnia relative to good sleepers and to compare the subjective evaluations of performance of those three groups relative to objective deficits.
METHOD

Participants
The participants were 60 older adults, including 20 individuals with insomnia and using benzodiazepines (INSBZ; 10 men and 10 women), 20 drug-free individuals with insomnia (INS; 9 men and 11 women), and 20 self-defined good sleepers (GS; 11 men and 9 women). All participants were 55 years of age or older. Participants with insomnia had to meet the following inclusion criteria: (a) subjective complaint of insomnia, defined as difficulties initiating and/or maintaining sleep; (b) insomnia present at least three nights per week for more than 6 months; (c) complaint of at least one negative daytime consequence attributed to insomnia; and (d) insomnia or its perceived consequences causing marked distress or significant difficulties in occupational or social functioning. Medicated insomnia participants had to use a benzodiazepine as a sleep aid for at least four nights per week for more than 3 months. GS did not meet any of the criteria for insomnia and did not take any sleep-promoting agents. Exclusion criteria for all participants were (a) presence of a significant medical (e.g., cancer) or neurological disorder (e.g., dementia), (b) a major psychopathology (e.g., depression, substance abuse), (c) presence of other sleep disorders (e.g., sleep apnea, periodic limb movements), (d) a score of 23 or higher on the Beck Depression Inventory (Beck, Steer, & Garbin, 1988) , (e) a score lower than 27 on the Mini-Mental State exam (Folstein, Folstein, & McHugh, 1975) , or (f) use of psychotropic or other medications (e.g., beta-blockers) known to alter sleep. These criteria are consistent with those of the International Classification of Sleep Disorders (American Sleep Disorders Association, 1990 ) and the Diagnostic and Statistical Manual of Mental Disorders (4th ed., or DSM-IV; American Psychiatric Association, 1994) for chronic and primary insomnia.
All participants were community-dwelling older adults with a mean age of 62.5 years (SD = 5.8) and a mean education of 13.4 years (SD = 3.7); they were predominantly married (76.7%) and retired (70.0%). Mean insomnia duration for the poor sleepers groups was 25.8 years (SD -15.7). Participants in the INSBZ condition had used benzodiazepines for sleep for an average duration of 13.5 years (SD = 10.0; range 1-34), with an average nightly use (lorazepam equivalent) of 1.6 mg (SD = 1.2) for an average of 6.6 nights a week (SD = 1.1). The benzodiazepines used included lorazepam (n = 11), flurazepam (n = 4), nitrazepam (n -3), and temazepam (n = 2).
Procedure
Participants were recruited through media advertisements. Following a phone interview, prospective participants underwent a multistep clinical evaluation, including a psychological assessment, a sleep evaluation, and a detailed medical history. The Structured Clinical Interview for Z)5'M-/V (Spitzer, Williams, Gibbon, & First, 1990 ) was administered to rule out major psychopathology. The Brief Symptom Inventory (Derogatis & Melisataros, 1983) , the Beck Depression Inventory , and the Beck Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1988) were used to obtain measures of intensity of global psychological distress, depressive, and anxiety symptomatology. Sleep measures included the Sleep Impairment Index (Morin, 1993) , the Beliefs and Attitudes about Sleep Scale (Morin, 1993) , and daily sleep diaries completed by the participants for a 2-week baseline period. Participants meeting initial criteria underwent three consecutive nights of sleep laboratory evaluation. Neuropsychological evaluations were performed approximately 1 hr on arising, the morning following the first night of sleep laboratory evaluation.
Measures
Polysomnography.-A standard polysomnographic montage including electroencephalographic, electromyographic, and electrooculographic monitoring was used. Sleep stages were scored by an experienced technician according to standardized criteria (Rechtschaffen & Kales, 1968) . Respiration and anterior tibialis electromyographs were recorded during the first night to detect sleep apnea or periodic limb movements. Because the first night is considered an adaptation night to the laboratory environment, polysomnographic data were based only on the recordings of the second and third nights. Dependent variables derived from polysomnography were the same as for the Sleep Diary (described below), with the addition of the percentages of time spent in each sleep stage.
The Sleep Diary (Morin, 1993 ) is a daily journal completed on arising each morning and providing subjective estimates of various sleep-wake parameters. Although a Sleep Diary does not reflect absolute values obtained from polysomnography, this assessment modality provides a reliable and valid index of insomnia (Coates et al., 1982) . Measures derived for the study were sleep-onset latency, denned as the time from initial lightsout to sleep onset; wake after sleep onset, referred to as the amount of time awake from the initial sleep onset to the last awakening; early morning awakening, defined as the time awake from the last awakening until actual arising time; frequency of awakenings, denned as the number of total awakenings during the night; total wake time, referred to as the summation of sleep-onset latency, wake after sleep onset, and early morning awakening; total sleep time, computed by subtracting total wake time from time in bed; time in bed, obtained by summing the total time elapsed from initial lights-out to final arising time; and finally, sleep efficiency, obtained by dividing total sleep time by time in bed and multiplying by 100. Once these variables were coded for each night, a mean was computed for the 2-week recording period.
Neuropsychological Measures
Vocabulary and Information (Wechsler, 1981) are the best measures of the General Intelligence factor of the Wechsler Adult Intelligence Scale-Revised (Wechsler, 1981) . They were used to verify that all groups had comparable levels of general mental abilities.
Verbal Paired Associates (Wechsler, 1987 ) is a paired wordlearning test. Six trials are provided to learn eight word pairs, although scoring is based on the first three trials. A single delayed recall is given 30 min later. This test measures verbal memory and learning abilities (Lezak, 1995; Spreen & Strauss, 1998) .
Visual Reproduction (Wechsler, 1987) consists of four printed designs that are shown to the participant. Following each exposure, the participants draw what they remember of the design. Delayed recall is given 30 min later. This task measures visual memory and visuospatial skills (Lezak, 1995; Spreen & Strauss, 1998) .
Digit Span (Wechsler, 1987) requires the participants to repeat forward or backward sequences of digits read by the examiner. Scores are the number of sequences correctly repeated. Digit Span forward is related to attention, and Digit Span backward measures concentration and working memory (Lezak, 1995; Spreen & Strauss, 1998) .
Symbol Digit Substitution (Wechsler, 1981) was used to assess visuomotor speed and coordination (Lezak, 1995; Schear & Sato, 1989) . The test is made up of four rows containing 100 small blank squares, each paired with a randomly assigned number from one to nine. Above these rows is a printed key that pairs each number with a different symbol. The task is to fill in as many blank spaces as possible with the appropriate symbol in 90 seconds. The score is the number of squares correctly filled in.
The Purdue Pegboard Test (Tiffin, 1968) measures manual dexterity and psychomotor speed (Lezak, 1995; Spreen & Strauss, 1998) . The task requires the participants to place as many pins as possible on a board within 30 s with the preferred hand, then with the nonpreferred hand, and then with both hands simultaneously. The score is the number of pairs of pegs placed correctly in the last synchronized trial.
The Trail Making Test (Reitan, 1958 ) is a test of complex visual scanning with a motor speed component (Lezak, 1995; Schear & Sato, 1989) . The participant must draw lines to connect consecutively numbered circles (Part A) and then to connect consecutively numbered and lettered circles on another worksheet by alternating between the two sequences (Part B).
The participant is urged to connect the circles "as fast as possible." The dependent measure is the time (in seconds) required to complete the task.
The Wilkinson Four-Choice Reaction Time Test (Wilkinson & Houghton, 1975) consists of a box on top of which are mounted a square of four lights and a corresponding square of four push buttons underneath. Lamps become illuminated according to a random sequence, and the participant has to press the right corresponding button as fast as possible. A computer device records reaction times, and the test lasts 10 min.
The Wisconsin Card Sorting Test (Grant & Berg, 1948) assesses the ability to form abstract concepts (Lezak, 1995; Spreen & Strauss, 1998) . Participants have to match response cards to one of four stimulus cards. After 10 consecutive correct placements in one category, the required sorting principle shifts to another category. This procedure continues until the participant has successfully completed six sorting categories, or until he or she has placed more than 64 cards in a single category. Scores are the number of categories completed and the percentage of perseverative errors (Heaton, Chelune, Talley, Kay, & Curtiss, 1993) .
Subjective Measures of Sleepiness, Current State, and Performance
The Stanford Sleepiness Scale (Hoddes, Dement, & Zarcone, 1972 ) is a single-item subjective measure of sleepiness. The participant is asked to rate his or her level of sleepiness/alertness on a scale ranging from 1 (feeling active and alert) to 7 (lost struggle to remain awake).
A series of ratings on 100-mm Visual Analogue Scales (based on Broman et al., 1992) were obtained for the following items: (a) alertness (very awake-very sleepy), (b) energy (very energetic-worn out), (c) mood (very happy-very depressed; very calm-very nervous), (d) tiredness (very alert-very tired), (e) tension (very relaxed-very tense), (f) motivation (very low-very high), (g) concentration (very low-very good), and (h) performance expectancy (very low-very high). Participants also evaluated their neuropsychological performance on 100-mm Visual Analogue Scales: (a) performance evaluation (very poor-very good), (b) satisfaction with performance (very dissatisfied-very satisfied), (c) performance in comparison to others of the same age (much worse-much better), and (d) performance in comparison to one's own real capacity (much worse-equal to).
RESULTS
Descriptive Variables
Table 1 summarizes descriptive statistics on selected sociodemographic, mental abilities, sleep, and psychological variables. We computed one-way analyses of variance (ANOVAs) to determine whether groups were equivalent on those variables. The three groups were equivalent on age, education, and general mental abilities (the Mini-Mental State Exam and the Wechsler Adult Intelligence Scale-Revised Vocabulary and Information subtests). There were significant group differences on self-report measures of insomnia severity such as the Sleep Impairment Index (p < .01) and the Beliefs and Attitudes About Sleep Scale (p < .01). Post hoc comparisons using Sheffe's tests revealed that INS and INSBZ, as expected, reported more severe sleep difficulties than GS on the Sleep Impairment Index (ps < .01), and post hoc comparisons on the Beliefs and Attitudes About Sleep Scale showed that INS (p < .01) and INSBZ (p< .05) had more dysfunctional beliefs about sleep than GS. No significant differences were found between INS and INSBZ on these two sleep variables. One-way ANOVAs on psychological measures yielded significant differences on the Brief Symptom Inventory, the Beck Depression Inventory, and the Beck Anxiety Inventory (allps < .01). The two insomnia groups reported more psychological distress and more depressive and anxious symptomatology relative to GS (all /?s < .01), but they were not different from each other.
Sleep-Wake Parameters
One-way ANOVAs were performed on sleep/wake variables obtained from polysomnographic and daily Sleep Diary evaluations. Means and standard deviations for those variables are presented in Table 2 . There was no significant difference among the three groups on polysomnographic measures, including sleep-onset latency, wake after sleep onset, early morning awakening, frequency of awakening, total wake time, total sleep time, and sleep efficiency, nor on the percentages of time spent in the different sleep stages (i.e., stages 1,2, 3^, and REM).
Conversely, one-way ANOVAs performed on the sleep diary data revealed significant differences on sleep onset-latency, wake after sleep onset, early morning awakening, total wake time, total sleep time, and sleep efficiency (allps < .01), but not on the frequency of awakening. Post hoc comparisons revealed that both insomnia groups had more sleep difficulties relative to GS (ps < .01) and that there was no significant difference between the INS and INSBZ groups.
Neuropsychological Measures
Principal-components analysis.-Means and standard deviations of the neuropsychological variables are shown in Table 3 . We performed a principal-components analysis with Varimax rotation (Kaiser normalization) on the 13 neuropsychological variables in order to reduce the number of variables and facilitate interpretation of the results. Using a minimum eigenvalue of 1.0, four components accounted for 66.8% of the cumulative variance. The first one (reflecting a visual and verbal memory component) accounted for 20.1% of the total variance. Components 2 (18.5 % of total variance) and 3 (15.7% of total variance) captured psychomotor speed and attention/concentration variables, respectively. Component 4 (12.5% of total variance) involved primarily executive functions. Although the loading of Trail Making on Component 2 appeared inconsistent with the literature (e.g., they are usually classified as measures of attention and/or executive functions, respectively), those results highlight the important role of motor speed in the execution of the tasks (Schear&Sato, 1989) .
We computed one-way multivariate analyses of variance (MANOVAs) to determine whether there were group differences on the four components identified with the principalcomponents analysis. There were no significant group differences on three of the components, including visual and verbal memory, F(8,108) = 1.43, p > .19; psychomotor speed, F(10,106) = 1.32, p > .23; and executive functions, F(4,l 12) = 2.04; p > .09. However, a significant difference was found between the three groups on the attention/concentration component, F(4,l 12) = 3.89;;? < .01. One-way ANOVAs showed sig- Comparisons with normative data.-Group means for each neuropsychological variable were compared with age-matched normative data in order to determine the extent to which performance was impaired. The data indicate that all three groups performed within the average range on measures of Visual Reproduction, Digit Span, and Digit Symbol Substitution (Wechsler, 1981 (Wechsler, , 1987 , as well as on the Purdue Pegboard Test (Spreen & Strauss, 1998) , the Trail Making Test (Spreen & Strauss, 1998) , and the Wisconsin Card Sorting Test (Heaton et al, 1993 
Subjective Ratings of Neuropsychological Performance
Group means and standard deviations on subjective measures of performance are presented in Table 4 . A one-way ANOVA on the Standard Sleepiness Scale measure revealed a significant difference among groups (p < .01). Post hoc comparisons revealed that only INS rated themselves as being more sleepy than GS (p < .01). A MANOVA computed on the first eight items rated on the Visual Analogue Scales yielded a significant overall effect, ^(16,100) = 4.00; p < .01. One-way ANOVAs revealed significant differences among the three groups on alertness, energy, mood, tiredness, stress/tension, and performance expectancy (all ps < .01) and on motivation (p < .05). Post hoc comparisons showed that INS (p < .01) and INSBZ (p< .05) rated themselves as less alert than GS. Both insomnia groups scored significantly lower than GS on levels of energy and mood (ps < .01) and higher on tiredness and stress/tension (ps < .01). Only the INS group reported lower motivation compared with GS (p < .05). INS rated their performance expectancy significantly lower than INSBZ and GS
(/7S<.01).
A MANOVA computed on the four questions related to the subjective evaluation of performance on the Visual Analogue Scales revealed a significant overall effect, /^SJOS) = 2.34,p< .05. One-way ANOVAs showed significant differences on evaluation of performance (p < .05), satisfaction with performance (p< .05), and performance compared with others (p < .01) and with one's own real capacities (p < .01). Post hoc comparisons indicated INS scored lower than GS on satisfaction with performance (p < .05) and level of performance compared with others (p < .01), and both insomnia groups scored lower than GS on performance level compared with one's own real capacities (ps < .05). Ratings of performance were lower in the two insomniac groups, compared with good sleepers, but the differences did not reach statistical significance (p < .09)
DISCUSSION
This study compared the objective and subjective evaluations of neuropsychological performance among medicated and unmedicated older adults with insomnia relative to good sleepers. Aside from attentional difficulties, there was little objective evidence of cognitive or psychomotor impairments among the insomnia groups. However, unmedicated poor sleepers subjectively evaluated their performance much more negatively than did good sleepers.
Participants with insomnia, whether they used benzodiazepines or not, displayed problems with both attention and, to a lesser extent, with concentration. Because sleep difficulties were common to both insomnia groups, it is plausible to attribute those attentional problems to insomnia rather than to medication intake. This finding corroborates a very common subjective complaint among insomnia sufferers about errors they make in their daily routines due to inattention. To the extent that individuals with insomnia are often hyperaroused (Bonnet & Arand, 1996; Stepanski, Zorick, Roehrs, Young, & Roth, 1988) , it is possible that this state of hyperarousal interferes with their capacity to screen the information coming from their environment and to pay attention only to important stimuli. This hyperarousal could also interfere with their ability to mobilize their energy, which would then be compensated by stronger efforts. This might explain the absence of deficit on tasks involving memory, executive functions, and psychomotor speed. It is also possible that complaints about their daily performance reflect frustration with the compensatory efforts they have to make in order to maintain an adequate performance. Related to this latter issue, Broman et al. (1992) observed that individuals with insomnia spend more energy in order to get things done and persevere longer at one task despite their tiredness relative to good sleepers, who slow down when tired.
The lack of significant impairments on measures of memory, executive, and psychomotor functions is consistent with other studies conducted with younger adults (Adam et al., 1986; Bromanetal., 1992; Sugerman, Stern, & Walsh, 1985) . One possible explanation for this lack of objective impairment is that when the demands of a task are brief, even poor sleepers are capable of mobilizing their resources in order to maintain an adequate performance (Bitwise, Carskadon, Seidel, Nekich, &Dement, 1991; Hart etal., 1995) . Perhaps a longer and more ecologically valid test battery (i.e., closer to real-life demands such as testing memory for recall of names or short stories) would be more sensitive to detect subtle deficits. The absence of significant impairments among chronic users of benzodiazepines is also consistent with findings of studies conducted with anxiety disorders patients Lucki et al., 1985 . These negative findings suggest that tolerance to the effects of benzodiazepines on neuropsychological functions develops with prolonged usage. It would be interesting to look at a group of older adults with a more recent onset of sleep disturbances and briefer exposure to benzodiazepines.
The drug-free insomnia participants subjectively rated their performance and actual state during testing much more negatively than did good sleepers. For instance, they had lower performance expectations, were less satisfied, and rated their actual performance as inferior to their potential or to the performance of other people of the same age. These findings indicate that the perceived daytime deficits are magnified and disproportionate in relation to objective impairments. This discrepancy is quite similar to the typical discrepancies between recorded and reported sleep disturbances (Morin, Stone, Trinkle, Mercer, & Remsberg, 1993) . Several factors may explain those discrepancies between subjective complaints and objective findings.
First, insomniacs may have negative expectancies about their performance that may bias their attention, augment symptom perceptions, and elicit negative emotional reactions that only reinforce their negative expectations (Mittenberg, DiGiulio, Perrin, & Bass, 1992) . Second, the two insomnia groups endorsed more dysfunctional beliefs and attitudes about their sleep and daytime functioning than did good sleepers. As discrepancies between one's current sleep patterns and desired sleep patterns may contribute to an insomnia complaint (Morin & Gramling, 1989) , similar discrepancies between objective performance and performance expectations could also contribute to complaints of daytime impairments. Perhaps the faulty performance expectations and negative evaluations reported by individuals with insomnia are only a variant of their faulty sleep expectations and dysfunctional beliefs.
Medicated insomnia participants rated their performance more negatively than did good sleepers only when they compared it to their own potential. The use of medication could explain this lack of difference on other subjective measures of performance. The influence of medication on self-evaluation has been tested in boys with attention deficit-hyperactivity disorder. Participants expected better performance on neuropsychological tests when told they were on medication and rated themselves more positively on self-evaluations when told they had taken medication (Whalen, Henker, Hinshaw, Heller, & Huber-Dressler, 1991) . It would be interesting to test this hypothesis in a double-blind fashion with older adults complaining of insomnia.
Psychological factors such as anxiety and depression can produce interference and decrease neuropsychological performance (Zarantonello, Slaymaker, Johnson, & Petzel, 1984) . Although both insomnia groups reported higher levels of depressive, anxious, and other psychological symptomatology relative to good sleepers, all scores remained within the normal range. Likewise, on the Visual Analogue Scales, individu-als with insomnia rated themselves as being more sleepy, more tired and tense, less alert, and less energetic than good sleepers. However, all scores remained at a relatively low severity level. Thus, these psychological variables do not seem to explain the few differences in performance found among the groups.
Although there was no significant difference among the three groups on any of the laboratory-recorded (i.e., polysomnographic) sleep measures, the sleep of both insomnia groups was generally more impaired than that of good sleepers. Because of the normal age-related changes occurring in sleep patterns (e.g., Prinz, Vitiello, Raskind, & Thorpy, 1990) , it is likely that these developmental changes may have contributed to a considerable overlap in sleep parameters between self-defined poor sleepers and noncomplaining older individuals. In contrast to objective polysomnographic measures, daily morning estimates (i.e., Sleep Diary) of sleep parameters discriminated between selfdefined poor and good sleepers.
Related to this issue, the use of laboratory polysomnography may have masked true differences in sleep parameters between poor and good sleepers and may have similarly minimized differences of daytime performance. The use of home-based sleep recording would be a preferable alternative for this type of study (Edinger et al., 1997a) . Also, because of the first-night effects observed in both good and poor sleepers during laboratory polysomnographs (Edinger et al., 1997b) , assessing participants following the second or third night in the laboratory might have eliminated this potential confounding factor. Finally, the small sample size may have provided only modest power to detect small but real differences on sleep and performance measures among the groups.
Despite these limitations, the present findings have several theoretical and clinical implications. First, they confirm the important role played by perceived daytime deficits in subjective insomnia complaints. Second, because of the significant discrepancies between perceived deficits and objective impairments, cognitive therapy may play an important role in the management of insomnia by altering those faulty perceptions and by decatastrophizing the impact of insomnia on daytime functioning (Morin, 1993; Morin, Colecchi, Stone, Sood, & Brink, 1999) . Finally, the finding that medicated insomniacs presented sleep disturbances of comparable severity to those of unmedicated ones raises important questions about the efficacy and indications of prolonged usage of hypnotic medications in elderly people. In light of these findings, as well as the known morbidity (e.g., falls, automobile accidents) associated with prolonged usage of benzodiazepines in elderly people, supervised withdrawal of those medications should be considered (Morin et al., 1999) .
In summary, the findings indicate that attention is a deficit common to both medicated and drug-free elderly individuals with insomnia. Despite relatively few objective differences among groups, older adults with insomnia, particularly unmedicated ones, perceived their performance much more negatively than did good sleepers. Additional research is needed to clarify the nature of the attentional difficulties in elderly individuals with insomnia and the implication of these difficulties in daily functioning, as well as the contributing role of performance expectancies and subjective evaluation of performance on neuropsychological performance.
